These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 395080

  • 1. Significance of renormalization of blood glucose concentration in diabetes mellitus.
    Pfeiffer EF.
    Horm Metab Res Suppl; 1979; (8):2-8. PubMed ID: 395080
    [No Abstract] [Full Text] [Related]

  • 2. The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system).
    Pfeiffer EF, Thum C, Clemens AH.
    Horm Metab Res; 1974 Sep; 6(5):339-42. PubMed ID: 4607598
    [No Abstract] [Full Text] [Related]

  • 3. Development of a closed-loop artificial pancreas.
    Kraegen EW, Whiteside R, Bell D, Chia YO, Lazarus L.
    Horm Metab Res Suppl; 1979 Sep; (8):38-42. PubMed ID: 395087
    [Abstract] [Full Text] [Related]

  • 4. Control algorithms for artificial beta cell.
    Clemens AH.
    Horm Metab Res Suppl; 1979 Sep; (8):35-8. PubMed ID: 395086
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Assessment of daily insulin requirements in diabetics with an artificial endocrine pancreas.
    Lambert AE, Buysschaert M, Lambotte L.
    Horm Metab Res Suppl; 1979 Sep; (8):120-7. PubMed ID: 395067
    [No Abstract] [Full Text] [Related]

  • 7. The development of Biostator, a Glucose Controlled Insulin Infusion System (GCIIS).
    Clemens AH, Chang PH, Myers RW.
    Horm Metab Res; 1977 Sep; Suppl 7():23-33. PubMed ID: 873440
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.
    Altomare E, Moulin JP, Tavares S, Bourelly N, Lassmann V, Vague P.
    Horm Metab Res Suppl; 1979 Sep; (8):110-5. PubMed ID: 395065
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The artificial beta cell (Biostator) in the adjustment of instable diabetics--results after 20 months.
    Beyer J, Wolf E, Cordes U, Hassingen W.
    Horm Metab Res Suppl; 1979 Sep; (8):127-31. PubMed ID: 395068
    [Abstract] [Full Text] [Related]

  • 14. Application of an artificial endocrine pancreas in the management of the diabetic surgical patient.
    Kerner W, Beischer W, Herfarth C, Pfeiffer EF.
    Horm Metab Res Suppl; 1979 Sep; (8):159-61. PubMed ID: 395073
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Continuous blood glucose monitoring in insulin-treated diabetes.
    Mirouze J, Collard F, Selam JL, Pham J.
    Horm Metab Res; 1977 Sep; Suppl 7():77-88. PubMed ID: 873445
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Progress toward an artificial pancreas?].
    Fantoli U.
    Recenti Prog Med; 1981 Apr; 70(4):437-8. PubMed ID: 7020008
    [No Abstract] [Full Text] [Related]

  • 20. [Artificial endocrine pancreas (author's transl)].
    Kruse-Jarres JD.
    J Clin Chem Clin Biochem; 1979 Jul; 17(7):457-63. PubMed ID: 383880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.